Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Levin

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Journal of Exposure Analysis and Environmental Epidemiology|April 28, 2005
Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult femalesSumitra Shantakumar, Marilie D Gammon, Sybil M Eng, et al.
ESC Heart Failure|July 18, 2018
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatmentMarco R Di Tullio, Min Qian, John L P Thompson, et al.
The American Journal of Cardiology|July 20, 2015
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or AspirinSiqin Ye, Bin Cheng, Gregory Y H Lip, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 26, 2016
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure　- Subanalysis of the WARCEF TrialTomoko S Kato, Marco R Di Tullio, Min Qian, et al.
Plos One|November 27, 2014
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialSusan Graham, Siqin Ye, Min Qian, et al.
Circulation. Heart Failure|April 9, 2015
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudyShunichi Homma, John L P Thompson, Min Qian, et al.
Circulation. Heart Failure|July 25, 2013
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trialShunichi Homma, John L P Thompson, Alexandra R Sanford, et al.
Journal of Cardiology|November 10, 2015
The first prognostic model for stroke and death in patients with systolic heart failureRonald S Freudenberger, Bin Cheng, Douglas L Mann, et al.
European Journal of Heart Failure|July 23, 2016
CHA<sub>2</sub> DS<sub>2</sub> -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythmSiqin Ye, Min Qian, Bo Zhao, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Stroke|June 30, 2016
Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction TrialMarco R Di Tullio, Min Qian, John L P Thompson, et al.
Journal of Exposure Analysis and Environmental Epidemiology|April 28, 2005
Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult femalesSumitra Shantakumar, Marilie D Gammon, Sybil M Eng, et al.
ESC Heart Failure|July 18, 2018
Left atrial volume and cardiovascular outcomes in systolic heart failure: effect of antithrombotic treatmentMarco R Di Tullio, Min Qian, John L P Thompson, et al.
The American Journal of Cardiology|July 20, 2015
Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or AspirinSiqin Ye, Bin Cheng, Gregory Y H Lip, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 26, 2016
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure　- Subanalysis of the WARCEF TrialTomoko S Kato, Marco R Di Tullio, Min Qian, et al.
Plos One|November 27, 2014
Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trialSusan Graham, Siqin Ye, Min Qian, et al.
Circulation. Heart Failure|April 9, 2015
Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudyShunichi Homma, John L P Thompson, Min Qian, et al.
Circulation. Heart Failure|July 25, 2013
Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trialShunichi Homma, John L P Thompson, Alexandra R Sanford, et al.
Journal of Cardiology|November 10, 2015
The first prognostic model for stroke and death in patients with systolic heart failureRonald S Freudenberger, Bin Cheng, Douglas L Mann, et al.
European Journal of Heart Failure|July 23, 2016
CHA<sub>2</sub> DS<sub>2</sub> -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythmSiqin Ye, Min Qian, Bo Zhao, et al.
Pageof 11